HPS3
Basic information
Region (hg38): 3:149129638-149173732
Links
Phenotypes
GenCC
Source:
- Hermansky-Pudlak syndrome 3 (Strong), mode of inheritance: AR
- Hermansky-Pudlak syndrome without pulmonary fibrosis (Supportive), mode of inheritance: AR
- Hermansky-Pudlak syndrome 3 (Definitive), mode of inheritance: AR
- Hermansky-Pudlak syndrome 3 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hermansky-Pudlak syndrome 3 | AR | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic | Prevention and treatment of bleeding episodes (eg, with DDAVP or platelet/RBC transfusions) can be effective, and aspirin-containing products should be avoided; Skin surveillance and protection can be beneficial; Prompt treatment of pulmonary infections (as well as avoidance of cigarette smoke) to maximize pulmonary function is indicated, including influenza and pneumococcus vaccination; Surveillance related to ophthalmologic, gastrointestinal, and other manifestations has been recommended in all individuals with HPS | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic; Pulmonary | 11455388; 20301464 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (94 variants)
- Hermansky-Pudlak syndrome 3 (19 variants)
- Hermansky-Pudlak syndrome (9 variants)
- HPS3-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HPS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 371 | 377 | ||||
missense | 221 | 233 | ||||
nonsense | 29 | 45 | 74 | |||
start loss | 1 | |||||
frameshift | 59 | 69 | 129 | |||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 27 | 36 | ||||
splice region | 14 | 58 | 3 | 75 | ||
non coding | 32 | 162 | 60 | 254 | ||
Total | 97 | 143 | 259 | 539 | 69 |
Highest pathogenic variant AF is 0.0000526
Variants in HPS3
This is a list of pathogenic ClinVar variants found in the HPS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-149129654-T-C | Hermansky-Pudlak syndrome 3 | Benign/Likely benign (Jul 09, 2018) | ||
3-149129674-C-T | Hermansky-Pudlak syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
3-149129681-C-A | Hermansky-Pudlak syndrome 3 | Uncertain significance (Jan 12, 2018) | ||
3-149129724-A-C | Uncertain significance (Feb 04, 2022) | |||
3-149129730-C-T | Hermansky-Pudlak syndrome 3 | Pathogenic (Jun 20, 2023) | ||
3-149129733-C-T | Hermansky-Pudlak syndrome 3 | Conflicting classifications of pathogenicity (Aug 16, 2022) | ||
3-149129735-G-C | Likely benign (Apr 06, 2023) | |||
3-149129738-C-G | Hermansky-Pudlak syndrome • Hermansky-Pudlak syndrome 3 | Pathogenic (Mar 30, 2024) | ||
3-149129741-C-T | Likely benign (Nov 09, 2021) | |||
3-149129742-C-T | Likely benign (Dec 23, 2021) | |||
3-149129744-G-A | Likely benign (Feb 08, 2022) | |||
3-149129744-G-T | Likely benign (May 20, 2023) | |||
3-149129746-AC-A | Pathogenic (Jan 10, 2020) | |||
3-149129747-C-T | Likely benign (Dec 20, 2020) | |||
3-149129750-G-A | Likely benign (Dec 02, 2023) | |||
3-149129750-G-C | Likely benign (Feb 14, 2023) | |||
3-149129753-C-T | Likely benign (Nov 24, 2022) | |||
3-149129756-G-C | Likely benign (Mar 18, 2022) | |||
3-149129758-C-A | Hermansky-Pudlak syndrome 3 | Pathogenic/Likely pathogenic (Feb 14, 2023) | ||
3-149129759-G-A | Likely benign (Apr 10, 2021) | |||
3-149129761-AG-CC | Uncertain significance (Sep 17, 2021) | |||
3-149129774-C-T | not specified • Hermansky-Pudlak syndrome 3 • Hermansky-Pudlak syndrome | Conflicting classifications of pathogenicity (Jul 16, 2024) | ||
3-149129777-C-T | Likely benign (Jun 03, 2023) | |||
3-149129781-C-T | Likely benign (Dec 06, 2022) | |||
3-149129786-G-A | Likely benign (Mar 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HPS3 | protein_coding | protein_coding | ENST00000296051 | 17 | 44149 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.94e-21 | 0.0999 | 125593 | 0 | 155 | 125748 | 0.000616 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.160 | 525 | 535 | 0.981 | 0.0000277 | 6529 |
Missense in Polyphen | 263 | 276.53 | 0.95107 | 3491 | ||
Synonymous | -0.378 | 215 | 208 | 1.03 | 0.0000110 | 1927 |
Loss of Function | 1.44 | 38 | 48.9 | 0.778 | 0.00000239 | 641 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000763 | 0.000761 |
Ashkenazi Jewish | 0.00179 | 0.00179 |
East Asian | 0.00158 | 0.00158 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.000505 | 0.000501 |
Middle Eastern | 0.00158 | 0.00158 |
South Asian | 0.00102 | 0.00101 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in early stages of melanosome biogenesis and maturation. {ECO:0000250|UniProtKB:Q91VB4}.;
Recessive Scores
- pRec
- 0.164
Intolerance Scores
- loftool
- 0.961
- rvis_EVS
- -1.28
- rvis_percentile_EVS
- 5.13
Haploinsufficiency Scores
- pHI
- 0.551
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.128
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hps3
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; pigmentation phenotype; hematopoietic system phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- organelle organization;pigmentation
- Cellular component
- cytoplasm;BLOC-2 complex
- Molecular function
- protein binding